-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165

Benzinga·11/06/2026 16:13:43
Listen to the news
Barclays analyst Christopher Pasquale maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $150 to $165.